Literature DB >> 24745470

Anxiety mediates the association between cannabis use and attenuated positive psychotic symptoms.

Lauren E Reeves1, Deidre M Anglin2, Richard G Heimberg1, Lauren E Gibson1, Anna M Fineberg1, Seth D Maxwell1, Connor M Kerns1, Lauren M Ellman3.   

Abstract

Cannabis use has been associated with a continuum of psychotic experiences. However, it is unclear whether mood and anxiety symptoms account for increases in attenuated positive psychotic symptoms (APPS) among cannabis users. We predicted that depression and anxiety symptoms would mediate the relation between cannabis use and APPS, and between cannabis use and endorsement of eight or more distressing APPS (D-APPS), a potentially more clinically meaningful group. Young adults (n=674) completed the Prodromal Questionnaire (PQ); Drug Use Frequency measure; Center for Epidemiologic Studies Depression Scale; State-Trait Anxiety Inventory, Trait Form, Anxiety Subscale; and Social Phobia Scale. Results indicated that symptoms of trait anxiety, but not symptoms of depression or social anxiety, mediated the relationship between cannabis use and APPS, as well as the relationship between cannabis use and D-APPS. Results indicate that symptoms of trait anxiety may play a role in the relation between cannabis use and APPS. Findings underscore the importance of considering clinical characteristics co-occurring with psychotic symptoms, such as affective symptoms, when examining the association between cannabis use and psychotic symptoms.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Anxiety; Attenuated psychotic symptoms; Clinical high risk; Prodromal; Psychosis

Mesh:

Year:  2014        PMID: 24745470     DOI: 10.1016/j.psychres.2014.03.040

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  15 in total

1.  Evidence That Environmental and Familial Risks for Psychosis Additively Impact a Multidimensional Subthreshold Psychosis Syndrome.

Authors:  Lotta-Katrin Pries; Sinan Guloksuz; Margreet Ten Have; Ron de Graaf; Saskia van Dorsselaer; Nicole Gunther; Christian Rauschenberg; Ulrich Reininghaus; Rajiv Radhakrishnan; Maarten Bak; Bart P F Rutten; Jim van Os
Journal:  Schizophr Bull       Date:  2018-06-06       Impact factor: 9.306

2.  Efficacy of Inhaled Cannabis on Painful Diabetic Neuropathy.

Authors:  Mark S Wallace; Thomas D Marcotte; Anya Umlauf; Ben Gouaux; Joseph H Atkinson
Journal:  J Pain       Date:  2015-04-03       Impact factor: 5.820

3.  Relationship between executive function, attachment style, and psychotic like experiences in typically developing youth.

Authors:  Melanie A Blair; George Nitzburg; Pamela DeRosse; Katherine H Karlsgodt
Journal:  Schizophr Res       Date:  2018-03-03       Impact factor: 4.939

4.  Psychosis risk screening in different populations using the Prodromal Questionnaire: A systematic review.

Authors:  Mark Savill; Jennifer D'Ambrosio; Tyrone D Cannon; Rachel L Loewy
Journal:  Early Interv Psychiatry       Date:  2017-08-06       Impact factor: 2.732

5.  Coping as a mediator of stress and psychotic-like experiences.

Authors:  A Ered; L E Gibson; S D Maxwell; S Cooper; L M Ellman
Journal:  Eur Psychiatry       Date:  2017-02-09       Impact factor: 5.361

6.  Traumatic life event exposure and psychotic-like experiences: A multiple mediation model of cognitive-based mechanisms.

Authors:  Lauren E Gibson; Lauren E Reeves; Shanna Cooper; Thomas M Olino; Lauren M Ellman
Journal:  Schizophr Res       Date:  2018-02-18       Impact factor: 4.939

7.  Attenuated positive psychotic symptoms and the experience of anhedonia.

Authors:  Shanna Cooper; Ann M Kring; Lauren M Ellman
Journal:  Early Interv Psychiatry       Date:  2017-06-09       Impact factor: 2.732

8.  The association between traumatic life events and psychological symptoms from a conservative, transdiagnostic perspective.

Authors:  Lauren E Gibson; Shanna Cooper; Lauren E Reeves; Deidre M Anglin; Lauren M Ellman
Journal:  Psychiatry Res       Date:  2017-02-22       Impact factor: 3.222

9.  Perceptual abnormalities in clinical high risk youth and the role of trauma, cannabis use and anxiety.

Authors:  Yun Lu; Catherine Marshall; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; Larry J Seidman; Ming T Tsuang; Elaine F Walker; Scott W Woods; Carrie E Bearden; Daniel Mathalon; Jean Addington
Journal:  Psychiatry Res       Date:  2017-08-31       Impact factor: 3.222

10.  Sleep quality, psychological symptoms, and psychotic-like experiences.

Authors:  Arielle Ered; Shanna Cooper; Lauren M Ellman
Journal:  J Psychiatr Res       Date:  2017-12-26       Impact factor: 4.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.